We had a server outage, and we're rebuilding the site. Most of the site features won't work. Thank you for your patience.
imc indymedia

Los Angeles Indymedia : Activist News

white themeblack themered themetheme help
About Us Contact Us Calendar Publish RSS
Features
latest news
best of news
syndication
commentary


KILLRADIO

VozMob

ABCF LA

A-Infos Radio

Indymedia On Air

Dope-X-Resistance-LA List

LAAMN List




IMC Network:

Original Cities

www.indymedia.org africa: ambazonia canarias estrecho / madiaq kenya nigeria south africa canada: hamilton london, ontario maritimes montreal ontario ottawa quebec thunder bay vancouver victoria windsor winnipeg east asia: burma jakarta japan korea manila qc europe: abruzzo alacant andorra antwerpen armenia athens austria barcelona belarus belgium belgrade bristol brussels bulgaria calabria croatia cyprus emilia-romagna estrecho / madiaq euskal herria galiza germany grenoble hungary ireland istanbul italy la plana liege liguria lille linksunten lombardia london madrid malta marseille nantes napoli netherlands nice northern england norway oost-vlaanderen paris/Île-de-france patras piemonte poland portugal roma romania russia saint-petersburg scotland sverige switzerland thessaloniki torun toscana toulouse ukraine united kingdom valencia latin america: argentina bolivia chiapas chile chile sur cmi brasil colombia ecuador mexico peru puerto rico qollasuyu rosario santiago tijuana uruguay valparaiso venezuela venezuela oceania: adelaide aotearoa brisbane burma darwin jakarta manila melbourne perth qc sydney south asia: india mumbai united states: arizona arkansas asheville atlanta austin baltimore big muddy binghamton boston buffalo charlottesville chicago cleveland colorado columbus dc hawaii houston hudson mohawk kansas city la madison maine miami michigan milwaukee minneapolis/st. paul new hampshire new jersey new mexico new orleans north carolina north texas nyc oklahoma philadelphia pittsburgh portland richmond rochester rogue valley saint louis san diego san francisco san francisco bay area santa barbara santa cruz, ca sarasota seattle tampa bay tennessee urbana-champaign vermont western mass worcester west asia: armenia beirut israel palestine process: fbi/legal updates mailing lists process & imc docs tech volunteer projects: print radio satellite tv video regions: oceania united states topics: biotech

Surviving Cities

www.indymedia.org africa: canada: quebec east asia: japan europe: athens barcelona belgium bristol brussels cyprus germany grenoble ireland istanbul lille linksunten nantes netherlands norway portugal united kingdom latin america: argentina cmi brasil rosario oceania: aotearoa united states: austin big muddy binghamton boston chicago columbus la michigan nyc portland rochester saint louis san diego san francisco bay area santa cruz, ca tennessee urbana-champaign worcester west asia: palestine process: fbi/legal updates process & imc docs projects: radio satellite tv
printable version - js reader version - view hidden posts - tags and related articles

Long-Term Pot-Use Study: No Ill Effects

by Peter Gorman, Special To HighWitness News Sunday, Jun. 30, 2002 at 10:50 PM

In the first study of its kind, four recipients of federally provided medical marijuana were examined for the health effects of their long-term cannabis use and none showed any serious adverse effects.

Van Gogh & Gauguin function LoadFrames(url1) { locstr = new String(frames.content.location); if (locstr.indexOf("home/intro.html") != -1 || locstr.indexOf("home/intro_nl.html") != -1) { loc = (url1); frames.content.location.replace("/home/content/content_frameset.html"); } else { frames.content.frameset.location.replace(url1); } } function LoadLang(lang) { if (lang == "nl") { frames.topnav.location.replace("/home/nav/topnav_nl.html"); frames.content.location.replace("/home/intro_nl.html"); } if (lang == "en") { frames.topnav.location.replace("/home/nav/topnav_en.html"); frames.content.location.replace("/home/intro.html"); } } isNS = document.layers ? true : false isIE = document.all ? true : false rowsize = 100; left = 48; right = 50; if (isNS) {rowsize = 106}; document.write(''); document.write(''); document.write('n'); document.write(''); document.write(''); document.write(''); document.write(''); document.write(''); In the first study of its kind, four recipients of federally provided medical marijuana were examined for the health effects of their long-term cannabis use-and none showed any serious adverse effects.

The Missoula Chronic Clinical Cannabis Use Study-headed by Montana neurologist Dr. Ethan Russo and Virginia nurse Mary Lynn Mathre, cofounder of Patients Out of Time-investigated "the therapeutic benefits and adverse effects" among patients receiving cannabis through the department of Health and Human Services' Compassionate Investigational New Drug program.

That program was closed to new applicants in 1991, but continues to supply medical marijuana to seven patients.
The four patients studied-one with glaucoma, one with chronic musculoskeletal pain, one with spasm and nausea, and one with spasticity from multiple sclerosis-were run through a battery of tests, including magnetic-resonance-imaging brain scans, chest X-rays, and neuropsychological, immunological and pulmonary-functions tests. The study provided the first opportunity to investigate the long-term physical effects of cannabis-smoking on patients who used a "known dosage of a standardized, heat-sterilized, quality-controlled supply of low-grade marijuana for 10-19 years."

The results, which will be published in the Journal of Cannabis Therapeutics in January 2002, showed "all four patients are stable with respect to their chronic conditions, and are taking many fewer standard pharmaceuticals than previously." Mild changes in pulmonary function were found in two of the four, but no cancer cells were detected. No other negative functions were discovered.

The study, conducted at St. Patrick's Hospital in Missoula, Montana, was sponsored by Patients Out of Time and funded by outside individuals.

"This is a positive result using a poor-quality medicine. What could we expect using a better quality cannabis?" Al Byrne, Patients Out of Time's other cofounder, told HT. Asked whether he thought the study would result in a reopening of the Compassionate IND program, Byrne bristled. "No. I don't think it will, but it should. I think the study's effect on the government will be that they will no longer be able to say that long-term therapeutic cannabis use is bad for you. But will the federal government pay it any heed? Probably not."

When asked why it took a nonprofit to organize the study rather than the government, Byrne noted that "I suppose because they suspected the result of the study would be positive and the government does not want anything positive said about cannabis use as medicine. That's the bottom line."

Note: The government says smoking pot is bad for your health, particularly in the long run. But four of the seven people it supplies have been looked at from every angle, and researchers conclude that their marijuana use hasn't hurt them a bit.

Newshawk: Ethan Russo, MD
Source: High Times (US)
Author: Peter Gorman, Special To HighWitness News
Published: August 1, 2001
Copyright: 2001 Trans-High Corporation
Contact: letters@hightimes.com
Website: http://www.hightimes.com/

Related Articles & Web Site:

Patients Out of Time
http://www.medicalcannabis.com/

Missoula Chronic Cannabis Use Research Study
http://www.maps.org/mmj/russo.4-2001.html

Journal of Cannabis Therapeutics
http://cannabisnews.com/news/thread8466.shtml

Herbal Answers
http://cannabisnews.com/news/thread8337.shtml

CannabisNews Search - Ethan Russo M.D.
http://cannabisnews.com/thcgi/search.pl?K=ethan+russo


Report this post as:

© 2000-2018 Los Angeles Independent Media Center. Unless otherwise stated by the author, all content is free for non-commercial reuse, reprint, and rebroadcast, on the net and elsewhere. Opinions are those of the contributors and are not necessarily endorsed by the Los Angeles Independent Media Center. Running sf-active v0.9.4 Disclaimer | Privacy